Health

FanIQ launches LP, a Landing Page creation and optimization product for sports teams, venues, and festivals

Leave a comment

[ad_1]

The ticket buying experience today does not allow for the type of 1-to-1 customization and personalization critical to engaging users in an increasingly competitive online advertising marketplace


NEW YORK (PRWEB)

FanIQ, the leading direct-to-consumer ticket selling platform for teams, venues, and festivals, has announced the launch of FanIQ LP, a landing page creation and optimization tool. Built specifically for mobile-first advertising, FanIQ LP tracks campaign performance on Snap, TikTok, Facebook, Instagram, YouTube, Google Display Network, and Twitter.

FanIQ sells through all major primary ticketing platforms including Ticketmaster, Seatgeek, AXS, Paciolan, Frontgate, Tixr and See Tickets, as well as offer platforms like Fevo. LP launch partners in sports include Pocono Raceway, Atlanta United FC, and the Los Angeles Sparks. Launch festivals partners include Pepsi Gulf Coast Jam.

“The ticket buying experience today does not allow for the type of 1-to-1 customization and personalization critical to engaging users’ in an increasingly competitive online advertising marketplace” said FanIQ founder, Jesse Lawrence. “LP provides ticket sellers a more efficient path to product discovery and merchandizing, whether across an entire season or a single game,” added Lawrence.

In addition to real-time conversion tracking, FanIQ LP also provides A/B testing templates and pre-set Google analytics tracking to measure 4-5 key post-click engagement metrics. LP also has an integration with Vozzi, a leading SMS marketing platform for teams to offer text-based lead generation for higher-touch products like season tickets and premium suites.

Over the last 5 years, FanIQ has worked with over 300 teams, venues, and promoters. Current and past clients include NASCAR, the Brooklyn Nets, Los Angeles Clippers, Columbus Crew, festivals like Governors Ball and Broccoli City and universities including University of Oregon, and Arizona State.

FanIQ’s sister company, TicketIQ, is a leading no-fee ticket marketplace that reaches millions fans every month through TicketIQ.com and the TicketIQ influencer network that includes over 500 publishers and social media influencers.

About the company:

TiqIQ, Inc. launched in 2009 as a white-label ticket selling platform for publishers like the Washington Post, Boston Globe, Atlanta Journal Constitution and SB Nation. Using first-party data from these publishing partners, the company leveraged programmatic media to help teams sell tickets direct-to-consumers through integrations with ticketing platforms, including Ticketmaster, Eventbrite, SeatGeek and Telecharge. Since its founding, the company has worked with hundreds of ticket sellers to promote unsold tickets and membership plans. In 2015, the company launched TicketIQ.com as a no-fee ticket buying marketplace.

Share article on social media or email:

[ad_2]

Health

9 Gardant Management Solutions Communities Achieve 2022 AHCA/NCAL Bronze National Quality Award

Leave a comment

[ad_1]

“We are extremely proud of the accomplishment of a portion of our portfolio receiving an AHCA/NCAL’s Bronze Quality Award,” says Rod Burkett, CEO of Gardant Management Solutions.


BOURBONNAIS, Ill. (PRWEB)

9 Gardant Management Solutions Communities Achieve

2022 AHCA/NCAL Bronze National Quality Award

National award signifies a formal commitment to continuous improvement in quality care

Nine assisted living and memory care communities managed by Gardant Management Solutions have been recognized as 2022 recipients of the Bronze – Commitment to Quality Award by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL) for its commitment to improving the lives of residents through quality care. The distinction is the first of three progressive award levels through the AHCA/NCAL National Quality Award Program. The program, presented by the leading association in long term and post-acute care, honors providers across the country that have demonstrated their commitment to improving quality of care for our nation’s seniors and people with disabilities.

The Gardant-managed communities to be honored with 2022 Bronze Awards are as follows:

Churchview Supportive Living

Churchview Supportive Living is an affordable assisted living community located in Chicago. The community is designed to serve low-income adults 65 years of age and older.

Gateway at River City

Located in Peoria, Illinois, GateWay at River City is an affordable assisted living community designed to serve adults 22 to 64 years of age with disabilities.

Heritage Woods of Chicago

Featuring 110 private apartments, Heritage Woods of Chicago is designed to serve adults 65 years of age and older. The community was recently among more than 20 Gardant-managed assisted living and memory care communities rated by U.S. News as being among the Best in the nation.

Heritage Woods of Gurnee

Heritage Woods of Gurnee is located in Lake County, Illinois. The affordable assisted living community is designed to serve adults 65 years of age and older.

Heritage Woods of Rockford

Heritage Woods of Rockford is an affordable assisted living community located in Winnebago County, Illinois. The community is designed to serve adults 65 years of age and older and was one of more than 20 Gardant-managed communities to be recognized by U.S. News as among the best for assisted living and memory care in the nation.

Heritage Woods of Sterling

Located in Whiteside County, Illinois, Heritage Woods of Sterling is an affordable assisted living community that serves adults 65 years of age and older. The community was one of more than 20 Gardant-managed communities to be recognized by U.S. News as among the best in the country for assisted living and memory care.

Heritage Woods of Newburgh

Located in Warrick County, Indiana, Heritage Woods of Newburgh is designed to serve adults of all incomes 62 years of age and older.

Oasis at 30th

Located on the east side of Indianapolis, Oasis at 30th features 124 apartments. The community is designed to serve low-income adults 55 years of age and older.

Gull Creek

Gull Creek is located in Berlin, Maryland, and features assisted living and memory care apartments. In 2021, Coastal Style magazine named Gull Creek the top assisted living provider in Worcester County.

In the past three years, 47 assisted living and memory care communities managed by Gardant have been recognized with Bronze awards.

“We are extremely proud of the accomplishment of a portion of our portfolio receiving an AHCA/NCAL’s Bronze Quality Award,” says Rod Burkett, CEO of Gardant Management Solutions. “This recognition is due to the dedicated efforts provided by the staff and management teams at these communities throughout the year, and it is indicative of their dedication to serving residents and committing to ongoing quality improvement. We are extremely thankful every day for their compassion and dedication!”

Created by AHCA/NCAL in 1996, the National Quality Award Program is a rigorous three-level process that is reviewed and judged by trained experts against a set of nationally recognized standards for organizational excellence. The standards of the Baldrige Performance Excellence Program help organizations achieve superior performance to improve quality of life and care of long term care residents and staff.

Providers begin the quality improvement process at the Bronze level, where they develop an organizational profile with essential performance elements such as vision, mission statement, and key strengths and challenges. Bronze applicants must also demonstrate their ability to implement a sustainable performance improvement system. Trained examiners review each application to determine if the center has met the demands of the criteria. As recipients of the Bronze – Commitment to Quality award, these communities may now move forward in developing approaches and achieving advanced levels of performance that meet the Silver – Achievement in Quality award criteria.

“Quality care is always top of mind for providers, and this achievement celebrates the commitment and fortitude of all nine Gardant-managed communities to find ways to enhance the lives of its patients and residents,” said the AHCA/NCAL National Quality Award Board of Overseers Chair Tammy Kelly.

The awards will be celebrated during AHCA/NCAL’s 73rd Convention & Expo in Nashville, Tennessee, on October 9-12, 2022.

###

ABOUT GARDANT MANAGEMENT SOLUTIONS

Gardant Management Solutions was built on the foundation that operating communities with dignity, compassion and enriched services would drive financial results. Our expertise in developing & operating environments that inspire vitality in our residents will create tangible business value for you.

We applaud figures 49 awards received from 48 communities that have achieved Bronze Award status in the past four years. We appreciate their commitment to quality improvement and to our mission of enriching the lives of residents by providing them with the Love, Compassion, and Dignity they deserve in addition to the personal assistance, help with medications, and support services they need.

15 Gardant-managed communities won the Bronze Award in 2021 including Cambridge House of Maryville, Cambridge House of O’Fallon, Cedar Grove, Deer Path Supportive Living, Eagle Ridge of Decatur, Grand Prairie of Macomb, Heritage Woods of Bolingbrook, Heritage Woods of McHenry, Heritage Woods of Noblesville, Heritage Woods of Ottawa, Heritage Woods of Watseka, Lacey Creek, Oasis at 56th, Prairie Winds of Urbana, and White Oaks at McHenry.

26 Gardant-managed communities won the Bronze Award in 2020 including Belvedere Senior Housing, Cambridge House of Swansea, Evergreen Village at Bloomington, Glasswater Creek of Lafayette, Hellenic Senior Living of Indianapolis, Hellenic Senior Living of New Albany, Heritage Woods of Batavia, Heritage Woods of Belvidere, Heritage Woods of Benton, Heritage Woods of Centralia, Heritage Woods of Charleston, Heritage Woods of DeKalb, Heritage Woods of Dwight, Heritage Woods of Freeport, Heritage Woods of Huntley, Heritage Woods of Manteno, Heritage Woods of Minooka, Heritage Woods of Moline, Heritage Woods of Mt. Vernon, Heritage Woods of Plainfield, Heritage Woods of South Elgin, Heritage Woods of Yorkville, St. Anthony of Lansing, The Lodge at Summers Pointe, White Oaks at Heritage Woods of South Elgin, and White Oaks at Spring Street.

For more information about the Bronze Award, click here.

ABOUT AHCA/NCAL

The American Health Care Association and National Center for Assisted Living (AHCA/NCAL) represent more than 14,000 non-profit and proprietary skilled nursing centers, assisted living communities, sub-acute centers, and homes for individuals with intellectual and development disabilities. By delivering solutions for quality care, AHCA/NCAL aims to improve the lives of the millions of frail, elderly and individuals with disabilities who receive long term or post-acute care in our member facilities each day. For more information, please visit http://www.ahcancal.org.

[ad_2]

Health

CISCRP, DIA Collaborate on 5K Run & Walk Event to Recognize All Clinical Trial Volunteers

Leave a comment

[ad_1]

News Image

“We are hopeful that many of our members and other clinical research professionals attending DIA 2022 will participate in the 5K in appreciation of the clinical trial participants who help make new treatments possible,” says Emily Daniele, Associate Director, Marketing, DIA.


BOSTON and HORSHAM, Pa. (PRWEB)

The Center for Information and Study on Clinical Research Participation (CISCRP) and the Drug Information Association (DIA), two independent nonprofit organizations, are excited to announce the upcoming Medical Heroes Appreciation 5K Run & Walk in Chicago. This event celebrates the volunteers and healthcare professionals who help make new treatments possible for everyone and aims to raise awareness about the important role that clinical research plays in advancing public health. CISCRP will host the Medical Heroes Appreciation 5K Run & Walk with the support of DIA, held in conjunction with the DIA’s Global Annual Meeting in Chicago, June 19-23, 2022. The 5K event will take place on Monday, June 20, 2022 at Burnham Park, Lake Front Trail, from 6:30 – 7:45AM. Participants are encouraged to register early, as space is limited. To register, visit https://www.eventbrite.com/e/journey-to-better-health-medical-heroes-appreciation-5k-run-walk-tickets-262625970347

“Medical Heroes are the millions of people who take part in clinical trials in an effort to help advance public health and the future of medicine,” says CISCRP’s Founder and Board Chair, Ken Getz. “The goal of our 5K event is to raise public awareness and appreciation for these individuals, and to celebrate and honor them for giving the gift of participation in clinical research.”

Chicago-area running and walking enthusiasts, patients, caregivers, clinical research professionals, as well as CISCRP and DIA supporters are invited to participate and attend the event. Proceeds from the 5K will support education and outreach programs to patients and families interested in learning more about the clinical research process, highlight insights on public perceptions, and provide plain language resources to help make clinical trial participation accessible for everyone.

“We’re excited to partner with CISCRP to host another Medical Heroes Appreciation 5K Run & Walk event at our annual meeting this year,” says Emily Daniele, Associate Director, Marketing, DIA. “We are hopeful that many of our members and other clinical research professionals attending DIA 2022 will participate in the 5K in appreciation of the clinical trial participants who help make new treatments possible.”

This event is being sponsored by SDC Clinical, IQVIA, Veristat, Horizon Therapeutics, Ora, Inc., Synteract, Javara, Amicus Therapeutics, and WCG.

Past 5K participants share:

“I participated in the 5K with my colleagues, and we had a blast. This race is not only a great team-building activity, but also a chance to learn a lot more about clinical research.”

“I have participated in many races, but especially liked the Medical Heroes 5K. I was glad to show my appreciation for the many volunteers and researchers who move medicine forward.”

Check-in on the day of the event, June 20th, begins at 6 AM. The 5K Run & Walk will begin at 6:30 AM at Burnham Park, Lake Front Trail, Chicago. Racers will receive bibs, t-shirts, an athlete certificate, and the chance to win fun branded giveaways. For more information about the 5K event, to volunteer, register, or become a sponsor, visit https://www.ciscrp.org/event/2022-medical-heroes-appreciation-5k-run-walk/ .

About CISCRP

CISCRP is a 501(c)(3) nonprofit organization dedicated to informing, educating, and engaging the public and patients as partners in the clinical research process. CISCRP provides a library of clinical research resources, programs, and services. Visit http://www.ciscrp.org for more information.

About DIA

DIA members represent the largest global network of life sciences professionals and stakeholders coming together to collaborate, discuss, and problem-solve challenges facing the life sciences field in an increasingly complex and interconnected world. These efforts aim to inspire better policies, regulations, science, research and development, and ultimately better patient outcomes worldwide. Learn more at https://www.diaglobal.org/en.

Share article on social media or email:

[ad_2]

Health

Top NYC Hernia Surgeon Mark Zoland M.D. of Core Surgical Conducting Upcoming Lecture at the Hospital for Special Surgery in NYC

Leave a comment

[ad_1]

News Image

“I am looking forward to sharing my knowledge on this topic with my colleagues at the HSS in September,” says Dr. Mark Zoland.


NEW YORK (PRWEB)

Dr. Mark Zoland has unparalleled knowledge and experience in areas such as hernia repair, groin pain, pelvic pain and sports-related groin/pelvic injuries, as well as non-surgical treatment recommendations. The Hospital for Special Surgery (HSS) will be hosting Dr. Zoland for an informative lecture on pain in the groin region, where the abdominal musculature attaches to the pubis, which is referred to as a “sports hernia,” “athletic pubalgia,” or “core muscle injury” and has become a topic of increased interest due to its challenging diagnosis. Identifying the cause of chronic groin pain is complicated because significant symptom overlap exists between disorders of the proximal thigh musculature, intra-articular hip pathology and disorders of the abdominal musculature, and Dr. Zoland will present a comprehensive review of the pathoanatomic features.

Dr. Mark Zoland is a general surgeon who has specialized in groin and pelvic pain. By focusing specifically on this area of the body, he straddles many surgical and medical disciplines and is able to offer a unique perspective on this difficult topic. Dr. Zoland graduated from Columbia University and earned his medical degree from Cornell University Medical College. He has been board-certified and a fellow of the American College of Surgeons since 2001. Dr. Zoland leads an elite medical team at Core Surgical in New York City and has presented at institutions such as Harvard, Hospital for Special Surgery, Columbia and Cornell. With multiple areas of expertise, including minimally invasive and laparoscopic surgery, conventional hernia surgery, sports hernia surgery and abdominal surgery, he offers decades of experience to help patients and educate other surgeons.

“I am looking forward to sharing my knowledge on this topic with my colleagues at the HSS in September,” says Dr. Mark Zoland.

More about Dr. Mark Zoland:

Both Dr. Zoland and the trusted medical team at Core Surgical in NYC utilize innovative techniques and advanced technology to achieve the best results for all types of patients, including treating high-level professional athletes in the NBA, NFL, MLS, MLB and NHL. Core Surgical is located at 133 E 58th Street, Suite 703 in New York City. To schedule a consultation with Dr. Mark Zoland or for more information about Core Surgical, please visit http://www.coresurgicalmd.com or call (212) 628-8771.

Share article on social media or email:

[ad_2]

Health

Clear Labs to Address NGS for Near Real-Time Surveillance and Outbreak Response at ASM Microbe 2022 in Washington, D.C.

Leave a comment

[ad_1]

News Image

This week, Clear Labs, the leader in fully automated, next-generation sequencing (NGS) for turnkey genomic surveillance and diagnostics, is attending ASM Microbe.


SAN CARLOS, Calif. (PRWEB)

This week, Clear Labs, the leader in fully automated, next-generation sequencing (NGS) for turnkey genomic surveillance and diagnostics, is attending ASM Microbe. The conference aims to drive discovery, innovation and collaboration across the full spectrum of microbiology. Clear Labs Chief Scientific Officer and Chief Operating Officer Ramin Khaksar is leading a session about the value of Near Real-Time Surveillance for Outbreak Response, while CEO Sasan Amini will join Dr. Khaksar at the close of the event for the ASM Clin Micro Open 2022.

WHEN: Friday, June 10, 2022, 8:45 am – 9:15 am ET: Clear Labs Chief Scientific Officer and Chief Operating Officer Ramin Khaksar on “NGS for Near Real-Time Surveillance and Outbreak Response by Public Health and Clinical Labs”

  • From variant surveillance to antimicrobial resistance characterization, the applications of NGS in clinical microbiology are paramount in infectious disease management. But time-intensive workflows, costs, skilled labor requirements, and bioinformatic interpretation have stunted this technology’s wide scale adoption and use in the public health and clinical microbiology fields. This session will focus on applications of NGS in the clinical microbiology field, solutions to challenges encountered with NGS, and development of NGS data analysis pipelines in order to guide public health response plans. During the session, speakers will share how they overcame technical obstacles associated with NGS in order to successfully employ this technology during the SARS-CoV-2 pandemic. NGS technology helped guide public health decision-making regarding the Covid-19 pandemic, and the prospects of NGS toward the response of other infectious diseases is promising. At the conclusion of the oral abstract presentations, a panel will discuss exciting new applications using NGS technologies.

Sunday, June 12 through Monday, June 13, 2022: Clear Labs CEO Sasan Amini joins CSO and COO Ramin Khaksar at the ASM Corporate Council’s Clin Micro Open (CMO) starting immediately after the close of ASM.

  • The CMO is a forum that brings together laboratory and industry leaders to discuss current and potential issues affecting the future of diagnostic clinical microbiology. There are two main subject areas covered at the CMO, which include pandemic preparedness and antimicrobial susceptibility testing (AST) breakpoints. The participants will present the keynote talks followed by roundtable discussions with the intent of formulating recommendations for future activities or collaborations.

WHERE: Walter E. Washington Convention Center

Exhibit Hall A-C

801 Mount Vernon Place, N.W.

Washington, D.C. 20001

Clear Labs will also be featuring a new scientific poster at the event, entitled “Comparison of modified ARTIC v4 and Midnight primers for SARS-CoV-2 Whole Genome Sequencing on an automated sequencing platform,” which will be presented by Shadi Shokralla, Associate Director of Assay Development.

With more than 500 cutting-edge sessions across 15 scientific tracks, ASM Microbe delivers a rich program that makes it easy to navigate and find new science across specialities. Clear Labs is debuting a new look at this year’s show – and will be at booth #813. For more information about Clear Labs and upcoming events, visit https://www.clearlabs.com/newsroom/.

About Clear Labs

Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs liberates genomics to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy for detection and surveillance of infectious diseases. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow’s novel pathogens.

Share article on social media or email:

[ad_2]

Health

Sinclair Energy Based Device Division Introduces V-VR, a Powerful, Clinically Proven Solution with Co-Polar RF™ for Vaginal Rejuvenation

Leave a comment

[ad_1]

V-VR Handpiece

“It’s truly an honor to bring the V-VR to the masses, a revolutionary solution that can and will change women’s lives!” Andrea Trofimuk, Sinclair North America, CEO.


LONDON (PRWEB)

Sinclair launches the V-VR handpiece to complete its women’s health solution. Throughout a woman’s life, hormonal and physical changes, such as pregnancy and menopause, can adversely affect vaginal health. These intimate concerns often go untreated due to embarrassment, lack of treatment availability awareness, or the desire to avoid invasive surgeries. At the forefront of women’s health, Sinclair created a new, non-invasive, pain-free vaginal rejuvenation treatment, the V-VR.


  • 50% of post-menopausal women are affected by vaginal dryness, which can cause persistent itching, burning and irritation

  • 40% of women are affected by vaginal laxity which can result in a loss of sexual sensation


With Sinclair’s new V-VR treatment, practitioners can now perform non-invasive, safe and quick vaginal treatments, providing superior results. The V-VR handpiece is compatible with all Viora V-Series platforms.

V-VR offers two patented non-invasive RF technologies:

The non-invasive Co-Polar RF™ Technology has the benefit of delivering bipolar RF energy with the controlled ability of a monopolar configuration – preventing unexpected energy spread of “hot spots”. The CORE™ Technology selectively delivers RF energy to controlled depths from superficial mucosa to the vaginal muscular layer.

“I’ve been using Sinclair’s Viora V-VR handpiece now for more than 6 months and achieved amazing results with it. The patients that have benefited the most so far are my vaginal atrophy patients, dyspareunia patients and even some of my pelvic pain patients have benefited from the V-VR treatment,” said Dr. Jennifer Hill, MD of Suffolk Pelvic Medicine. “Quickly, I can see a change in the vaginal pH, which also lends itself medically to helping control, urinary tract infections, and other things like that. I’ve had a lot of patient feedback that even after one treatment, they’ve noticed a big difference, especially with dyspareunia. I’ve had a lot of patients that may not even be sexually active that say that they feel a big difference after getting V-VR treatments. So, it’s been fantastic to my practice, and I’ve been really happy with the results.”

“Making a difference in patients’ lives and positively impacting our customers revenue potential is complementary; being able to do both is of the utmost importance, and is a driving force behind Viora’s developments. Viora’s leadership team is predominantly female, which gives us a unique perspective and a better understanding of the needs women have, and the challenges in which our bodies face. It’s truly an honor to bring the V-VR to the masses, a revolutionary solution that can and will change women’s lives!” Andrea Trofimuk, Sinclair North America, CEO.

”Following in the footsteps of our hugely successful bi-polar and fractional RF modalities for labia tightening and rejuvenation, the ReVive and Fusion® Revive, the addition of the V-VR handpiece, provides our women’s health professionals a one treatment station for both vulvovaginal conditions. This is an enormous advantage for both patients and practitioners,” said Dr. Inna Belenky, VP Marketing & Clinical Affairs

Sinclair unveiled the V-VR handpiece at the IMCAS World Congress on June 3-5th at the Le Palais des Congrès de Paris in Paris, France. In addition to V-VR, Sinclair displayed the complete V-Series multi-technology platform line, Fusion® kits and the other leading medical aesthetic devices.

The Viora V-Series multi-technology platform line now provides a complete solution for any clinic with a flexible and scalable solution for customers, with the use of interchangeable handpieces. This enables customers to acquire each specific technology as they need it, as well as ensuring easy upgrades and the implementation of additional technologies, when developed. Customers also benefit from Sinclair’s unique combination protocols ensuring the highest clinical results.

In Europe, V-VR is indicated for electrocoagulation of soft tissues for vulvovaginal laxity. In the United States, V-VR is indicated for temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation.

About Sinclair Pharma

Sinclair Pharma is an international company operating in the fast growth, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies in both the injectable and EDB segments. Both divisions are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. Sinclair is planning entry to multiple new geographic markets and line extension launches over the next few years. The Group has an established sales and marketing presence in the EU markets, Brazil, Mexico, Colombia, UAE, Hong Kong and South Korea and a network of international distributors.

For more information, visit http://www.sinclairpharma.com

About Viora

Sinclair acquired Viora, a market leader in advanced medical aesthetic research, development and manufacturing in February of 2022; making Viora a cornerstone in the genesis of Sinclair’s Energy Device Division. With a presence in more than 65 countries, Viora’s non-invasive products address a wide range of solutions, treating today’s most commonly requested applications used in anti-aging, body & facial contouring, cellulite reduction, acne clearance, hair removal and more.

For more information, visit http://www.vioramed.com.

Share article on social media or email:

[ad_2]

Health

PFAS Treatment, Sources, Testing and Disposal — What F&B Manufacturers Must Know, Upcoming Webinar Hosted by Xtalks

Leave a comment

[ad_1]

F&B manufacturers need to understand this growing challenge and implement a holistic approach to evaluate and mitigate this growing concern using innovative technologies that best suit their specific needs.


TORONTO (PRWEB)

Per- and polyfluoroalkyl substances (PFAS) have been present in commercial and industrial products since the 1940s. However, only recently have the consequences of this been investigated and mitigation measures deployed. PFAS are of great concern since they are highly resistant to biodegradation which complicates their treatment. In addition, PFAS are bioaccumulative which increases their health risks. The presence of PFAS in surface waters, groundwater, wastewater, soil and air affects the environment and is of increasing concern. Food and Beverage (F&B) manufacturers can prioritize this problem by installing effective PFAS treatment solutions. F&B manufacturers need to understand this growing challenge and implement a holistic approach to evaluate and mitigate this growing concern using innovative technologies that best suit their specific needs.

In this webinar, the featured speaker will provide an overview of the PFAS landscape as it relates to F&B manufacturing. The speaker will cover what regulations exist as well as the sources and types of PFAS. Attendees will learn about sample and testing requirements, treatment approaches and issues around disposal and destruction. The speaker will also discuss a case study where a multinational F&B company integrated a PFAS treatment solution.

Join John Peichel, Global Market Developer, SUEZ, for the live webinar on Thursday, June 23, 2022, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit PFAS Treatment, Sources, Testing and Disposal — What F&B Manufacturers Must Know.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

[ad_2]

Health

Techson IP Announces Exclusive Partnership Agreement with Bright Green Corporation

Leave a comment

[ad_1]


AUSTIN, Texas (PRWEB)

Techson IP (“Techson”), a patent and intellectual property strategy consulting firm, and Bright Green Corporation (BGXX) (“Bright Green”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell legally under federal and state laws cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced an exclusive partnership agreement to collaborate on the acquisition and future development of intellectual property (IP) across the cannabis industry. Techson will be the exclusive broker and will research, review and assess new IP available in the sector and being offered to Bright Green for acquisition or licensing. Additionally, Techson will provide its strategic innovation research and consulting services as Bright Green ramps up its grow operations and brings its world-class research and development facilities online. Terms of the agreement were not disclosed.

“Techson has been building out its patent advisory practice since 2019 by focusing on emerging industries where intellectual property development and procurement have traditionally taken a back seat to productization. Spring boarding off our success as a leading patent research consultancy, we are helping clients build strategic patent portfolios that are complementary to the anticipated growth and revenue ahead,” says CEO of Techson, Luke Barbin. “Cannabis has unprecedented potential, and we believe that Bright Green will have an edge on the competition because they are willing to commit significant resources now to build a longer-term technology vision for the cannabis industry. Techson has already secured dozens of cannabis patent families and will look to sign and deploy these innovations in market leaders like Bright Green.”

“Bright Green is focused on strategically expanding its reach to serve both pharmaceutical opportunities as well as cannabis medical research product development on an unprecedented scale,” said Bright Green’s CEO, Ed Robinson. “As we accelerate these focused operations to meet the growing global cannabis demand, this partnership will enable us to strategically expand our current patent and IP portfolio in tandem. The team at Techson is the right partner for Bright Green and we look forward to this important collaboration.”

If you own or represent cannabis-related intellectual property that you would like Techson to review, please contact info (at) techsonip (dot) com.

About Techson IP

Founded in 2015 in Austin, Texas by IP attorneys, research experts and technologists, we are a patent and intellectual property strategy consulting firm with our experiential roots in patent transactions, patent research and building technology automation that provides us with a competitive advantage in IP.

Techson’s founders and executives have worked with and for the world’s largest patent owners and law firms. Techson’s researchers have conducted more than 20,000 research projects, and its 200+ clients include Fortune 500/Global 2000 corporations and Am Law 100 law firms. Its principals have also supported over $200 million in patent transactions and helped companies secure tens of millions in private equity and venture capital investments. Learn more visit http://www.techsonip.com or contact Techson at info (at) techsonip (dot) com.

About Bright Green

Bright Green is one of the very few companies selected by the US government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. Its conditional approval based on already agreed terms from the U.S. Drug Enforcement Administration gives Bright Green the opportunity to advance its vision of improving quality of life through the opportunities presented by cannabis-derived therapies. To learn more, visit http://www.brightgreen.us.

Media Contact

BrightGreen (at) edelman (dot) com

Share article on social media or email:

[ad_2]

Health

Largest Asian Physician Group in NYC Appoints Seasoned Healthcare Executive as President

Leave a comment

[ad_1]


NEW YORK (PRWEB)

Rendr, the largest primary care-focused multi-specialty physician group dedicated to serving medically underserved Asian Americans in New York City, recently appointed Mr. Dean Lin as President and Board Member. Lin will report to Dr. Richard Park, CEO of Rendr, and lead the execution of Rendr’s strategic growth plan.

“I am honored to join Rendr and work with a group of mission driven physicians and other healthcare professionals who are dedicated to provide world-class health care services to medically underserved Asian communities,” said Lin. “I am committed to helping Rendr scale up from the great foundation its founding physicians and management team have built, and make Rendr a truly value-based provider that delivers the highest quality of health care.”

Prior to joining Rendr, Lin has served as President of the Physician Services Division and Care Transformation at Hackensack Meridian Health, one of the largest healthcare systems in New Jersey. His extensive executive experience at Hackensack Meridian Health also includes Hospital President of Ocean Medical Center. Before working for Hackensack Meridian Health, Lin has held executive positions at Geisinger Health System and Intermountain Healthcare.

About Rendr

Rendr is the largest primary care driven, multi-specialty physician group dedicated to serving medically underserved Asian populations in New York City. The physician group was founded in 2019 with a mission to provide world-class health care services and serve kindness to immigrant communities. Currently, it has more than 90 medical providers serving a patient population of approximately 100,000 at thirty-eight locations across Brooklyn, Manhattan, and Queens. Rendr is financially backed by Ascend Capital Partners, a healthcare focused private equity firm.

Share article on social media or email:

[ad_2]

Health

Houston Dermatologist Develops Groundbreaking New Class Of Topical Pharmaceuticals That Has Potential To Reduce The Opioid Crisis In America

Leave a comment

[ad_1]

“As a dermatologist and a pharmacist, it is an honor to bring forth a new topical classification (Dermaceuticals) and a lotion that has helped people relieve various chronic pain within minutes” – Dr. Milton Moore.


HOUSTON (PRWEB)

Dr. Milton D. Moore, a leading dermatologist and founder & CEO of Moore Unique Skin Care, LLC and Moore Unique Dermatology, today announced two new innovative products under the brand name Moore Relief Dermaceuticals: Moore Relief Pain Discomfort Lotion and Moore Relief Skin Revitalizing & Burn Lotion.

Initially formulated as moisturizing treatments for eczema and other conditions that cause skin irritation, Moore Relief Pain Discomfort Lotion and Moore Relief Skin Revitalizing & Burn Lotion are scientifically proven, fast-acting, effective therapies that help relieve neuropathic skin discomfort and help heal burn wounds. The findings of Dr. Moore’s clinical research in the development of these products were published in a recent article in the Journal of Dermatology Research (peer reviewed).

Dr. Moore has seen an increase of patients who were depending upon opioids to help relieve their pain. Some of those patients chose to forego opioids and switch to the topical Moore Relief Pain Discomfort lotion which has none of the side effects of opioid medications. They even reported an even greater relief of pain in less than 5 minutes, and relief lasted for a longer period.

In clinical research tests, Dr. Moore’s patients applied the Moore Relief Pain Discomfort Lotion topically to areas in which they experienced recurring pain from carpal tunnel syndrome, sciatica, back, knee, fibromyalgia, and diabetic neuropathy. Most patients reported apparent relief of 75 to 100 percent, and the relief lasted from 7 to 24 hours with one application.

In other clinical studies, the Moore Relief Revitalizing Burn Repair Lotion was applied topically to the burn scars of Dr. Moore’s patients recovering from first and second-degree burns. The lotion was proven to help accelerate healing from several months down to as little as 14 days with return of normal skin color, while preventing the appearance of scars and providing immediate cooling and pain relief.

Both patent-pending Moore Relief Dermaceuticals products are formulated with moisturizing and anti-inflammatory agents such as aloe vera, extracts of algae, argan oil as well as other natural ingredients. These products use Dr. Moore’s patented transdermal delivery system, which enables the active ingredients to be absorbed by the skin quickly. Each ingredient provides a unique contribution to the effectiveness of the products by cooling, moisturizing, and repairing damaged skin areas.

“As a dermatologist and a pharmacist, it is an honor to bring forth a new topical classification (Dermaceuticals) and a lotion that has helped people relieve various chronic pain within minutes,” said Dr. Milton Moore. “I’d like to thank Swedish chemist Nil Lofgren who developed xylocaine systemic injection in 1943, and Heinrich Braun for the local form in 1903. I am also excited about the relief that burn patients can get from the burn discomfort lotion to reduce pain to a minimum, and speed up healing and repair.”

About Dr. Milton D. Moore

Dr. Milton Moore specializes in all types of dermatological skin procedures and cosmetic surgeries. Dr. Moore has 25 years of experience addressing the skin care needs of men, women, boys and girls. He has addressed all skin types from sensitive to dry, oily and damaged. Dr. Moore continues to innovate and push the envelope to create solutions for his customers. In the last decade, Dr. Moore stunned the industry creating his own signature line of skin care products. He combined his expertise as a pharmacist and his experience as a dermatologist to develop a unique blend of products to solve an assortment of skin related issues. To review more product information and patient testimonials, visit http://www.MOORERELIEF.COM

Media Contact

Jason Geller

JMediaHouse, LLC

jason@jmediahouse.com

212-920-0398

Share article on social media or email:

[ad_2]

Press Release News Wire Service